Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 1741 AL 1755

A Randomized Double-Blind Placebo-Controlled Phase III Trial of Selegiline Monotherapy for Early Parkinson Disease

Mizuno Y, Hattori N, Kondo T, Nomoto M, Origasa H, Takahashi R, Yamamoto M, Yanagisawa N.

Clin Neuropharmacol. 2017 Sep/Oct;40(5):201-207. doi: 10.1097/WNF.0000000000000239.

Is telomere length a biomarker of neurological disorders?

Thanseem I, Viswambharan V, Poovathinal SA, Anitha A.

Biomark Med. 2017 Sep;11(9):799-810. doi: 10.2217/bmm-2017-0032.

Benzoate and Sorbate Salts: A Systematic Review of the Potential Hazards of These Invaluable Preservatives and the Expanding Spectrum of Clinical Uses for Sodium Benzoate

Piper JD, Piper PW.

Compr Rev Food Sci Food Saf. 2017 Sep;16(5):868-880. doi: 10.1111/1541-4337.12284. Epub 2017 Jul 14.

Activation mechanisms of the E3 ubiquitin ligase parkin

Panicker N, Dawson VL, Dawson TM.

Biochem J. 2017 Aug 30;474(18):3075-3086. doi: 10.1042/BCJ20170476.

Cannabinoids in Parkinson's Disease

Stampanoni Bassi M, Sancesario A, Morace R, Centonze D, Iezzi E.

Cannabis Cannabinoid Res. 2017 Feb 1;2(1):21-29. doi: 10.1089/can.2017.0002. eCollection 2017.

Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases

Moreno JA, Telling GC.

Methods Mol Biol. 2017;1658:219-252. doi: 10.1007/978-1-4939-7244-9_16.

Reliability and Validity of 39-Item Parkinson's Disease Questionnaire and Parkinson's Disease Quality of Life Questionnaire

Jesus-Ribeiro J, Vieira E, Ferreira P, Januário C, Freire A.

Acta Med Port. 2017 May 31;30(5):395-401. doi: 10.20344/amp.8202. Epub 2017 May 31.

Alpha-Synuclein to the Rescue: Immune Cell Recruitment by Alpha-Synuclein during Gastrointestinal Infection

Labrie V, Brundin P.

J Innate Immun. 2017;9(5):437-440. doi: 10.1159/000479653. Epub 2017 Sep 2.

Iron metabolism and its detection through MRI in parkinsonian disorders: a systematic review

Pietracupa S, Martin-Bastida A, Piccini P.

Neurol Sci. 2017 Dec;38(12):2095-2101. doi: 10.1007/s10072-017-3099-y. Epub 2017 Sep 2.

Can Biomarkers Help the Early Diagnosis of Parkinson's Disease?

Le W, Dong J, Li S, Korczyn AD.

Neurosci Bull. 2017 Oct;33(5):535-542. doi: 10.1007/s12264-017-0174-6. Epub 2017 Sep 2.

Tongue tremor as a manifestation of atypical Parkinsonism treated with coaxial deep brain stimulation of thalamus and subthalamic area

Toda H, Asanuma K, Kondo T, Terada Y, Saiki H.

Parkinsonism Relat Disord. 2017 Nov;44:154-156. doi: 10.1016/j.parkreldis.2017.08.023. Epub 2017 Aug 24.

Bio-effectiveness of the main flavonoids of Achillea millefolium in the pathophysiology of neurodegenerative disorders- a review

Ayoobi F, Shamsizadeh A, Fatemi I, Vakilian A, Allahtavakoli M, Hassanshahi G, Moghadam-Ahmadi A.

Iran J Basic Med Sci. 2017 Jun;20(6):604-612. doi: 10.22038/IJBMS.2017.8827.

[Erythropoietin treatment may improve cognition in neuropsychiatric disorders]

Kjær KS, Hageman I, Wörtwein G, Jørgensen MB, Miskowiak KW.

Ugeskr Laeger. 2017 Aug 14;179(33):V01170037.

[Challenges in the differential diagnoses of parkinsonism]

Bech S, Haugbøl S, Winge K.

Ugeskr Laeger. 2017 Aug 14;179(33):V03170235.

Current approaches to the treatment of Parkinson's Disease

Ellis JM, Fell MJ.

Bioorg Med Chem Lett. 2017 Sep 15;27(18):4247-4255. doi: 10.1016/j.bmcl.2017.07.075. Epub 2017 Jul 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias